sellWeak10b5-1 plan
LaBarre Michael J. sold $1.1M of HALO
SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC.. 20,000 shares at an average of $53.50, traded Oct 15, 2024, filed Oct 16, 2024.
Warning score
10Value
$1.1M
20,000 shares
Holdings after
173,756
-11% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-025233, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 15, 2024 | MOption exercise Common Stock10b5-1 | +5,509 | $16.65 | $92k | 179,265 | Oct 16, 2024 |
| Oct 15, 2024 | MOption exercise Common Stock10b5-1 | +4,491 | $19.98 | $90k | 183,756 | Oct 16, 2024 |
| Oct 15, 2024 | SOpen-market sale Common Stock10b5-1 | -9,923 | $53.74 | $533k | 173,833 | Oct 16, 2024 |
| Oct 15, 2024 | SOpen-market sale Common Stock10b5-1 | -77 | $54.25 | $4,177 | 173,756 | Oct 16, 2024 |
| Oct 16, 2024 | MOption exercise Common Stock10b5-1 | +10,000 | $19.98 | $200k | 183,756 | Oct 16, 2024 |
| Oct 16, 2024 | SOpen-market sale Common Stock10b5-1 | -10,000 | $53.26 | $533k | 173,756 | Oct 16, 2024 |
| Oct 15, 2024 | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -5,509 | $0.00 | $0 | 6,352 | Oct 16, 2024 |
| Oct 15, 2024 | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -4,491 | $0.00 | $0 | 36,608 | Oct 16, 2024 |
| Oct 16, 2024 | MOption exercise Option to Purchase Common Stockderivative10b5-1 | -10,000 | $0.00 | $0 | 26,608 | Oct 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.